Keratitis Global Clinical Trials Review, H1, 2016
SKU ID :GD-10173168 | Published Date: 30-Apr-2016 | No. of pages: 71Description
TOC
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Keratitis to Ophthalmology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Keratitis to Ophthalmology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Keratitis Therapeutics Clinical Trials 29
Prominent Drugs 31
Clinical Trial Profile Snapshots 32
Appendix 68
Abbreviations 68
Definitions 68
Research Methodology 69
Secondary Research 69
About GlobalData 70
Contact Us 70
Disclaimer 70
Source 71
Tables & Figures
List of Tables
Keratitis Therapeutics, Global, Clinical Trials by Region, 2016* 6
Keratitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8
Keratitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Keratitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10
Keratitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11
Keratitis Therapeutics Clinical Trials, North America, Top Countries, 2016* 12
Keratitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 13
Keratitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 14
Proportion of Keratitis to Ophthalmology Clinical Trials, G7 Countries (%), 2016* 15
Keratitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16
Keratitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17
Proportion of Keratitis to Ophthalmology Clinical Trials, E7 Countries (%), 2016* 18
Keratitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19
Keratitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20
Keratitis Therapeutics, Global, Clinical Trials by Phase, 2016* 21
Keratitis Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22
Keratitis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23
Keratitis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24
Keratitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25
Keratitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26
Keratitis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 28
Keratitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 30
Keratitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 31
List of Figures
Keratitis Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Keratitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Keratitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Keratitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10
Keratitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11
Proportion of Keratitis to Ophthalmology Clinical Trials, G7 Countries (%), 2016* 15
Keratitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16
Keratitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17
Proportion of Keratitis to Ophthalmology Clinical Trials, E7 Countries (%), 2016* 18
Keratitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19
Keratitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20
Keratitis Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21
Keratitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22
Keratitis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23
Keratitis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24
Keratitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25
Keratitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26
Keratitis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27
Keratitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29
Keratitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 31
GlobalData Methodology 69
Companies
Novartis AG
Dompe Farmaceutici S.p.A.
Valeant Pharmaceuticals International, Inc.
Santen Pharmaceutical Co., Ltd.
RegeneRx Biopharmaceuticals, Inc.
Gene Signal International SA
Allergan Plc
Ajanta Pharma Limited
Adapt Produtos Oftalmologicos Ltda
A. Menarini Industrie Farmaceutiche Riunite Srl
- PRICE
-
$2500$7500